Resiliencia de un centro de investigación en el “Vacunagate”

Eduardo  Ticona

doi:10.36393/spmi.v35i3.685

Resilience of a research center in the “Vacunagate”

Eduardo Ticona Universidad Nacional Mayor de San Marcos. Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo, Lima, Perú https://orcid.org/0000-0002-6556-1082

DOI: https://doi.org/10.36393/spmi.v35i3.685

Keywords: SARS-Cov-2, COVID-19, vaccine, Sinopharm, Vacunagate

Abstract

The author, principal investigator of the Research Center of the Universidad Nacional Mayor de San Marcos, presents his point of view according to which his
center complied with the provisions of the Sinopharm vaccine protocol, maintaining an ethical and scientific integrity and, nevertheless, was immersed in the
notorious “Vacunagate” case.

Downloads

Download data is not yet available.

PDF (Español (España))

Published

2022-08-29

How to Cite

Ticona, E. (2022). Resilience of a research center in the “Vacunagate”. Revista De La Sociedad Peruana De Medicina Interna, 35(3), e685. https://doi.org/10.36393/spmi.v35i3.685

Download Citation

Issue

Vol 35 No 3 (2022)

Section

Opinión

This work is licensed under a Creative Commons Attribution 4.0 International License.